June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Advanced Flow Cytometry and Machine Learning for Profiling Ocular Leukocytes in Human Inflammatory Eye Disease
Author Affiliations & Notes
  • Joan Kalnitsky
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
  • Rose Mathew
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
  • Chen Yu
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
  • Sejiro Littleton
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
    Immunology, Duke University, Durham, North Carolina, United States
  • Cole Beatty
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
    Immunology, Duke University, Durham, North Carolina, United States
  • Hazem Mousa
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
  • Dilraj Grewal
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
  • Victor L Perez
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
  • Daniel Saban
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
    Immunology, Duke University, Durham, North Carolina, United States
  • Footnotes
    Commercial Relationships   Joan Kalnitsky None; Rose Mathew None; Chen Yu None; Sejiro Littleton None; Cole Beatty None; Hazem Mousa None; Dilraj Grewal None; Victor Perez Dompe, Code C (Consultant/Contractor), Regener-Eyes, Code C (Consultant/Contractor), Salten, Code C (Consultant/Contractor), Alcon, Code F (Financial Support), EBN, Code F (Financial Support), Kiora, Code I (Personal Financial Interest), Trefoil , Code I (Personal Financial Interest); Daniel Saban Roche, Code C (Consultant/Contractor), AbbVie, Code C (Consultant/Contractor), Genentech, Code C (Consultant/Contractor), Novartis, Code C (Consultant/Contractor), Dompe, Code F (Financial Support)
  • Footnotes
    Support  NIH/NEI R01EY021798; P30EY005722
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3916. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Joan Kalnitsky, Rose Mathew, Chen Yu, Sejiro Littleton, Cole Beatty, Hazem Mousa, Dilraj Grewal, Victor L Perez, Daniel Saban; Advanced Flow Cytometry and Machine Learning for Profiling Ocular Leukocytes in Human Inflammatory Eye Disease. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3916.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Inflammation contributes to the pathophysiology of eye diseases, including in uveitides, infections, traumas, and nonimmune entities such as in inherited retinal dystrophies. Ocular leukocyte profiling by flow cytometry (FC) of fluid specimens such as tear washes, aqueous humor taps, or vitreous samples (as appropriate) may therefore help better characterize, discover markers, and find therapeutic targets in treating inflammation. Conventional FC, however, is limited to measuring defined bands in wavelengths, whereas spectral FC measures bands across the entire spectrum, allowing us to to increase our parameters by nearly 4-fold. Here, we established a 36-parameter panel to examine eye samples from human ocular immune disease.

Methods : We utilized a 36-parameter panel provided by Cytek Biosciences that was devised with the Cytek panel design tool. Single color, or unstained controls, were carried out with human PBMCs from consented healthy human subjects, or compensation beads. Using SpectroFlow software, we spectrally unmixed the data from each flourochrome. Once completed, we ran our panel on samples from consented healthy subject PBMCs, tear washes from consented ocular surface immune disease patients, and vitreous samples from consented posterior uveitis patients.

Results : Clustering and dimensionality reduction were used for annotating PBMCs based on lineage-defining and supporting markers. Each cluster-defined population was validated by traditional gating schemes for adaptive and innate lymphocytes, plasma cells, granulocytes, and mononuclear phagocyte populations. As we previously showed the utility of FC in characterizing immune cells in ocular surface disease (Reyes NJ. et al., 2018), we tested our panel on tear washes from ocular surface disease patients. We also tested vitreous samples from posterior uveitis patients. We were able to successfully integrate PBMC dimensionality reduction maps (UMAP) with ocular sample data, although not all circulating populations were represented.

Conclusions : We demonstrate the utility of 36 parameter spectral FC. Anchored with PBMC cluster mapping, even low input ocular samples of 100 cells or less could be integrated and reliably annoted for B and T cells, natural killer cells, mononuclear phagocytes, and granulocytes. Hence, this approach may be a powerful tool to help characterize inflammation in various eye diseases.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×